David Beasley, PhD
Department of Microbiology & Immunology
Phone: (409) 772-1120
Fax: (409) 747-2437
Education: PhD, 1999, Queensland University of Technology (QUT), Brisbane, Australia
BASc (Hons), 1993, Queensland University of Technology (QUT), Brisbane, Australia
BASc (Medical Laboratory Science), 1992, Queensland University of Technology (QUT), Brisbane, Australia
Overview: Molecular basis of virulence and antigenic
variations between West Nile virus (WNV) strains; arbovirus vaccines
and diagnostics; Good Laboratory Practice.
Dr. Beasley's research currently focuses on the molecular basis of
virulence and antigenic variations between strains of West Nile virus.
His lab's wider research activities include studies related to the
development of improved diagnostic and therapeutic reagents and vaccines
for flaviviruses and other arboviruses. Dr. Beasley is Co-Director of
the Keiller/GNL BSL3 laboratories, Director of the GNL Regulatory
Services Core, and directs research activities associated with an
NIH-sponsored animal models contract to undertake GLP compliant animal
and in vitro studies.
Search PubMed Database for Publications